Has Alla Gruman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,432 in general payments to Alla Gruman, MD across 345 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alla Gruman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alla Gruman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alla Gruman, MD

Dermatology · Osprey, FLNPI 1629087911

Payments from drug & device makers

$7,432in general payments, 2019–2025

Across 345 payments — averaging $21.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sun Pharmaceutical Industries Inc.$761
Sanofi$677
Regeneron Healthcare Solutions, Inc.$594
Johnson & Johnson$547
UCB, Inc.$530
Novartis$445
plus $4K from 37 others

What the payments were for

Grants$200%
Food & beverage$7,412100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sun Pharmaceutical Industries Inc.	35	$761
Sanofi	22	$677
Regeneron Healthcare Solutions, Inc.	22	$594
Johnson & Johnson	42	$547
UCB, Inc.	21	$530
Novartis	21	$445
Lilly USA, LLC	17	$434
AbbVie	17	$340
Mayne Pharma Commercial LLC	16	$336
Ortho Dermatologics, A Division Of Bausch Health US, LLC	19	$326
Pfizer	15	$316
Incyte Corporation	9	$208
Boehringer Ingelheim	7	$166
Janssen Scientific Affairs, LLC	2	$163
E.r. Squibb & Sons, L.L.C.	8	$150
LEO Pharma Inc.	6	$139
Galderma Laboratories, L.p.	7	$128
Arcutis Biotherapeutics, Inc.	6	$111
Amgen	4	$100
Biofrontera Inc.	4	$80
Genentech USA, Inc.	4	$69
Dermavant Sciences, Inc.	3	$68
Strata Skin Sciences, Inc.	6	$67
Almirall LLC	3	$63
VYNE Pharmaceuticals Inc.	3	$61
Convatec Inc.	3	$53
Journey Medical Corporation	2	$45
Elekta, Inc.	1	$41
Krystal Biotech Inc	2	$39
Dermira, Inc.	2	$38
Organogenesis Inc.	1	$37
Helsinn Therapeutics (U.S.), Inc.	2	$36
Aclaris Therapeutics, Inc.	2	$34
Sanofi-aventis U.S. LLC	1	$33
Mimedx Group, Inc.	2	$32
AstraZeneca	1	$31
Verrica Pharmaceuticals Inc.	1	$27
Encore Dermatology Inc.	1	$22
Bristol Myers Squibb	1	$21
Paratek Pharmaceuticals, Inc.	1	$17
Kyowa Kirin, Inc.	1	$17
Merz North America, Inc.	1	$16
Nabriva Therapeutics, PLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ILUMYA$123
DUPIXENT$119
Tremfya$105

How this compares

$7,432 in reported general payments places this provider in the 70th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024

$1,197,464

Medicare patients

1,710

Services billed

12,514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Monohydrate	473	$7,574
Betamethasone Dipropionate	113	$4,144
Ketoconazole	265	$3,694
Clobetasol Propionate	70	$2,559
Metronidazole	35	$2,485
Triamcinolone Acetonide	332	$2,224
Fluorouracil	13	$2,031
Tretinoin	50	$1,894
Clindamycin Phosphate	94	$1,792
Mupirocin	224	$1,207
Fluocinonide	22	$1,011
Fluocinolone AcetonideFluocinolone/Shower Cap	18	$839
Betamethasone Valerate	30	$731
Doxycycline Hyclate	58	$671
Econazole Nitrate	23	$609

Paid to pharmacies, not to this prescriber.

Other dermatology in Osprey

Michael SherlingLake Worth$78.9M
Seth FormanTampa$28.2M
Thomas TaylorTampa$13.6M
Frank DonHallandale Beach$7.5M
Francisco FloresMiramar$6.7M
Hector Wiltz JrMiami$6.4M
Javier Alonso-LlamazaresCoral Gables$5.6M
Eduardo WeissHollywood$5.5M
Francisco KerdelMiami$5.1M
Jason SluzevichJacksonville$4.8M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →